Five-year follow-up of allergic bronchopulmonary aspergillosis.
D000328:Adult; D000368:Aged; D000402:Airway Obstruction / Q000209:etiology; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D002908:Chronic Disease; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D004802:Eosinophilia / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008172:Lung Diseases, Fungal / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D011241:Prednisone / Q000627:therapeutic use*; D012129:Respiratory Function Tests; D012130:Respiratory Hypersensitivity / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012189:Retrospective Studies
D004205:Cromolyn Sodium; D011241:Prednisone